EyePoint Pharmaceuticals News

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 14 15:46

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Feb 2 15:26

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 24 15:30

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 24 15:21

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 22 23:00

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 22 23:00

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 21 23:00

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Jan 10 23:00

EyePoint Pharmaceuticals | 424B5: Prospectus

Dec 7, 2023 05:11

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 5, 2023 07:54

EyePoint Pharmaceuticals | 424B5: Prospectus

Dec 4, 2023 16:31

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 4, 2023 15:16

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 4, 2023 15:15

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 4, 2023 14:39

EyePoint Pharmaceuticals | EFFECT: Others

Oct 30, 2023 23:15

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 22, 2023 15:23

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Aug 22, 2023 15:17

EyePoint Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 26, 2023 06:00

EyePoint Pharmaceuticals | 424B5: Prospectus

Nov 18, 2021 16:13

EyePoint Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 17, 2021 05:09